Search

Author/Creator Zhou, Longen

1. A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemia. Issue 3 (22nd January 2013)

Authors:
Zhu, Jiewen; Zhou, Longen; Wu, Guikai; Konig, Heiko; Lin, Xiaoqin; Li, Guideng; Qiu, Xiao‐Long; Chen, Chi‐Fen; Hu, Chun‐Mei; Goldblatt, Erin; Bhatia, Ravi; Chamberlin, A. Richard; Chen, Phang‐Lang; Lee, Wen‐Hwa
Journal:
EMBO molecular medicine
Issue:
Volume 5:Issue 3(2013:Mar.)
Page Start:
353
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma. Issue 7 (2nd July 2021)

Authors:
Mustafa, Nurulhuda; Nee, Adina Huey Fang; Chooi, Jing Yuan; Toh, Sabrina Hui Min; Chung, Tae-Hoon; Selvarajan, Viknesvaran; Fan, Shuangyi; Ng, Siok Bian; Poon, Michelle; Chan, Esther; Lee, Joanne; Chee, Yen Lin; Jeyasekharan, Anand D; Zhou, Longen; Yang, Jennifer; Chng, Wee Joo
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗